Eli Lilly obesity pill disappoints in trial, sending shares down 12%
Rival Novo Nordisk’s stock climbs 12%
What's Your Reaction?
Like
0
Dislike
0
Love
0
Funny
0
Angry
0
Sad
0
Wow
0
